Functional signaling test identifies HER2 negative breast cancer patients who may benefit from c-Met and pan-HER combination therapyIan A. MacNeil, Lance Laing|Cell Communication and Signaling|2022Cited by 2
Synergistic Efficacy of Gedatolisib and Darolutamide in Prostate Cancer to Overcome Resistance to Androgen-Targeted TherapySalmaan Khan, Lance Laing|International Journal of Molecular Sciences|2025Cited by 0